Female Infertility Diagnosis & Treatment Market by Product, Treatment, Diagnosis, Cause of Infertility, End User - Global Forecast 2025-2030- Product Image

Sale

Female Infertility Diagnosis & Treatment Market by Product, Treatment, Diagnosis, Cause of Infertility, End User - Global Forecast 2025-2030

Report
199 Pages
October 2024
Region: Global
360iResearch™
ID: 5977741

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Female Infertility Diagnosis & Treatment Market grew from USD 1.81 billion in 2023 to USD 1.96 billion in 2024. It is expected to continue growing at a CAGR of 8.11%, reaching USD 3.14 billion by 2030.

Female infertility diagnosis and treatment encompass a range of medical evaluations and interventions aimed at identifying and addressing the causes of infertility in women. The necessity for these services is driven by increasing infertility rates due to factors such as higher maternal age, lifestyle changes, and rising prevalence of conditions like PCOS and endometriosis. Applications range from diagnostic tests, including hormone evaluations and imaging, to treatments like medication, surgery, and assisted reproductive technologies such as IVF. The end-use scope primarily includes specialized fertility clinics, hospitals, and research institutes seeking to improve outcomes and patient satisfaction. Market growth is influenced by factors like technological advancements, increased government support and funding for fertility treatments, and heightened awareness and acceptance of fertility interventions. The introduction of AI-driven fertility diagnostics and personalized medicine offers significant growth opportunities, where companies can focus on integrating advanced data analytics and genomics to enhance predictive accuracy and treatment effectiveness. However, the market is also challenged by high treatment costs, varying regulatory landscapes across regions, and ethical concerns surrounding certain reproductive technologies. These factors may limit accessibility and market expansion in certain areas. Innovations in non-invasive diagnostic techniques, affordable treatment options, and improved male infertility solutions can further push the market forward. Insight into the market nature reveals it is highly competitive, with continuous research and development being crucial for maintaining a competitive edge. By investing in cutting-edge technology and addressing cost and regulatory challenges, businesses can harness growth opportunities. Strategic partnerships and collaborations with healthcare providers and tech firms also emerge as viable strategies for market expansion. Such initiatives will drive business growth by enhancing operational capabilities and extending market reach.

Understanding Market Dynamics in the Female Infertility Diagnosis & Treatment Market

The Female Infertility Diagnosis & Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising prevalence of reproductive and fertility issues among women
- Government initiatives to promote access to reproductive healthcare solutions
- Expansion of fertility clinics across the world and expanding awareness about reproductive issues
Market Restraints
- Lack of skilled personnel and complexity of identifying and treating fertility issues
Market Opportunities
- Ongoing innovations to improve the effectiveness and accuracy of female infertility diagnosis and treatment solutions
- Favorable regulatory support for new innovations and solutions for managing reproductive issues
Market Challenges
- Concerns related to the accuracy and side effects of female infertility diagnosis and treatment solutions

Exploring Porter’s Five Forces for the Female Infertility Diagnosis & Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Female Infertility Diagnosis & Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Female Infertility Diagnosis & Treatment Market

External macro-environmental factors deeply influence the performance of the Female Infertility Diagnosis & Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Female Infertility Diagnosis & Treatment Market

The Female Infertility Diagnosis & Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Female Infertility Diagnosis & Treatment Market

The Female Infertility Diagnosis & Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Female Infertility Diagnosis & Treatment Market

The Female Infertility Diagnosis & Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Female Infertility Diagnosis & Treatment Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Cook Group Incorporated, CooperSurgical Inc., Ferring B.V., FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation, Genea Pty Limited, GlaxoSmithKline PLC, Halotech DNA S.L., Intas Pharmaceuticals Ltd., Lupin Limited, Merck & Co., Inc., Novartis AG, Sanofi SA, SCSA Diagnostics, Inc., Theramex by Kanga Health Ltd, and Vitrolife Sweden AB.

Market Segmentation & Coverage

This research report categorizes the Female Infertility Diagnosis & Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Accessories
- Equipment
- Media
Treatment
- Assisted Reproductive Technology
- Medication
- Surgery
Diagnosis
- Hysteroscopy
- Imaging Tests
- Ovulation Testing
Cause of Infertility
- Endometriosis
- Ovulatory Disorders
- Tubal Occlusion
End User
- Fertility Clinics
- Hospitals
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of reproductive and fertility issues among women
5.1.1.2. Government initiatives to promote access to reproductive healthcare solutions
5.1.1.3. Expansion of fertility clinics across the world and expanding awareness about reproductive issues
5.1.2. Restraints
5.1.2.1. Lack of skilled personnel and complexity of identifying and treating fertility issues
5.1.3. Opportunities
5.1.3.1. Ongoing innovations to improve the effectiveness and accuracy of female infertility diagnosis and treatment solutions
5.1.3.2. Favorable regulatory support for new innovations and solutions for managing reproductive issues
5.1.4. Challenges
5.1.4.1. Concerns related to the accuracy and side effects of female infertility diagnosis and treatment solutions
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing incorporation of media solutions as it support the growth and viability of embryos outside the body
5.2.2. End User: Fertility clinics' first-line choice for specialized reproductive care
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Female Infertility Diagnosis & Treatment Market, by Product

6.1. Introduction
6.2. Accessories
6.3. Equipment
6.4. Media

7. Female Infertility Diagnosis & Treatment Market, by Treatment

7.1. Introduction
7.2. Assisted Reproductive Technology
7.3. Medication
7.4. Surgery

8. Female Infertility Diagnosis & Treatment Market, by Diagnosis

8.1. Introduction
8.2. Hysteroscopy
8.3. Imaging Tests
8.4. Ovulation Testing

9. Female Infertility Diagnosis & Treatment Market, by Cause of Infertility

9.1. Introduction
9.2. Endometriosis
9.3. Ovulatory Disorders
9.4. Tubal Occlusion

10. Female Infertility Diagnosis & Treatment Market, by End User

10.1. Introduction
10.2. Fertility Clinics
10.3. Hospitals
10.4. Research Institutes

11. Americas Female Infertility Diagnosis & Treatment Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Female Infertility Diagnosis & Treatment Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Female Infertility Diagnosis & Treatment Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Lupin Introduces New Generic Infertility Treatment in the U.S. Market
14.3.2. Arva Health's Innovative At-Home Fertility Test for Indian Women
14.3.3. Trajan Scientific and German Startup Fertilly Introduce Microsampling-based Fertility Test Kits in Europe
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2023 VS 2030 (%)
FIGURE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 46. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 47. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 52. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 73. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 74. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 78. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 79. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 88. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 89. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 118. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 119. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 134. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 139. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 140. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 145. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 150. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 155. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 163. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 164. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 165. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 179. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 180. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 184. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 185. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 188. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 189. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 190. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 210. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 225. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Female Infertility Diagnosis & Treatment market, which are profiled in this report, include:

Bayer AG
Cook Group Incorporated
CooperSurgical Inc.
Ferring B.V.
FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation
Genea Pty Limited
GlaxoSmithKline PLC
Halotech DNA S.L.
Intas Pharmaceuticals Ltd.
Lupin Limited
Merck & Co., Inc.
Novartis AG
Sanofi SA
SCSA Diagnostics, Inc.
Theramex by Kanga Health Ltd
Vitrolife Sweden AB

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	199
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.96 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.14 Billion
Compound Annual Growth Rate	8.1%
Regions Covered	Global
No. of Companies Mentioned	16

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Female Infertility Diagnosis & Treatment Market

Exploring Porter’s Five Forces for the Female Infertility Diagnosis & Treatment Market

Applying PESTLE Analysis to the Female Infertility Diagnosis & Treatment Market

Analyzing Market Share in the Female Infertility Diagnosis & Treatment Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Female Infertility Diagnosis & Treatment Market

Strategic Recommendations for Success in the Female Infertility Diagnosis & Treatment Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Female Infertility Diagnosis and Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

Female Infertility - Market Insight, Epidemiology and Market Forecast - 2034

Female Infertility Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Female Infertility: Seven-Market Drug Forecast and Market Analysis

Female Infertility - Pipeline Insight, 2024